GAMBARAN NILAI TROMBOSIT PADA PASIEN TUBERCULOSIS PARU YANG MENDAPAT PAKET OBAT ANTI TUBERKULOSIS (OAT) DI RUMAH SAKIT UMUM DAERAH KOTA KENDARI

Authors

  • Muhammad Ilyas Yusuf Politeknik Bina Husada Kendari
  • Firdayanti Firdayanti Politeknik Bina Husada Kendari
  • Salmawati Salmawati Politeknik Bina Husada Kendari

DOI:

https://doi.org/10.46356/jakk.v3i2.112

Keywords:

Hematologi, Mikrobiologi

Abstract

ABSTRACT

Tuberculosis (TB) is an infectious disease that attacks the lungs caused by the bacteria Mycobacterium tuberculosis is transmitted through the air. One of the drugs used for TB disease rifampisin known as a cause of thrombocytopenia. This study aims to describe the number of platelets in patients receiving antituberculosis treatment medication package (OAT) in the General Hospital of City of Kendari. This type of research is descriptive , Automatic method. Based on the results of 18 samples of normal platelet values ​​obtained on the duration of treatment 2-6 months as many as 15 people (83.3%), while acquired decreased platelet count (thrombocytopenia) in the old first month of treatment as many as three people (16.7%).

Keywords :Tuberculosis lung, Anti tuberculosis drug, Platelet, RSUD Kendari city

 

ABSTRAK

 

Tuberkulosis (TB) adalah penyakit infeksi yang menyerang paru-paru yang disebabkan oleh kuman Mycobacterium tuberculosis yang penularannya melalui udara. Salah satu obat yang digunakan untuk penyakit TB yaitu rifampisin yang diketahui sebagai penyebab trombositopenia.Penelitian ini bertujuan untuk mengetahui gambaran nilai trombosit pada pasien tuberculosis paru yang mendapat perawatan paket obat anti tuberkulosis (OAT) di Rumah sakit Umum Daerah Kota Kendari. Jenis penelitian ini adalah deskriptif, pemeriksaan jumlah trombosit dilakukan menggunakan metode automatik.Berdasarkan hasil penelitian dari 18 sampel diperoleh nilai trombosit normal pada pasien dengan lama pengobatan 2-6 bulan sebanyak 15 orang (83,3%), sedangkan nilai trombosit tidak normal (trombositopenia) pada pasien  dengan pengobatan 1 bulan sebanyak 3 orang (16,7%) .

Kata kunci : Tuberkulosis paru, obat anti tuberkulosis, trombosit, RSUD Kota Kendari 

Additional Files

Published

2018-08-28

Issue

Vol. 3 No. 2 (2021): Jurnal Analis Kesehatan Kendari (JAKK) : Vol. 3 (2) Juni 2021)

Section

Articles

License

Authors who publish on JAKK can share their research in a number of ways. JAKK does not impose an embargo on published journals, meaning that researchers can access it openly after the article is published. Researchers who have subscribed to access to articles can also share.

JAKK already uses the Open Journal System (OJS) thereby enabling the final version of all published research articles to be placed in any digital archive immediately after publication. JAKK can automatically make feeds of open access articles available to any repository that wishes to receive them.

Authors who publish with this journal agree to the following terms:
* Authors retain copyright and grant the journal right of first publication, with licensed under a Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
* Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
* Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.